BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 36986840)

  • 1. Phenotyping Indices of CYP450 and P-Glycoprotein in Human Volunteers and in Patients Treated with Painkillers or Psychotropic Drugs.
    Darnaud L; Delage C; Daali Y; Trouvin AP; Perrot S; Khoudour N; Merise N; Labat L; Etain B; Bellivier F; Lloret-Linares C; Bloch V; Curis E; Declèves X
    Pharmaceutics; 2023 Mar; 15(3):. PubMed ID: 36986840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of Mutual Drug-Drug Interaction within Geneva Cocktail for Cytochrome P450 Phenotyping using Innovative Dried Blood Sampling Method.
    Bosilkovska M; Samer C; Déglon J; Thomas A; Walder B; Desmeules J; Daali Y
    Basic Clin Pharmacol Toxicol; 2016 Sep; 119(3):284-90. PubMed ID: 27009433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Cytochrome P450 Inhibition and Induction on the Phenotyping Metrics of the Basel Cocktail: A Randomized Crossover Study.
    Derungs A; Donzelli M; Berger B; Noppen C; Krähenbühl S; Haschke M
    Clin Pharmacokinet; 2016 Jan; 55(1):79-91. PubMed ID: 26123704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The basel cocktail for simultaneous phenotyping of human cytochrome P450 isoforms in plasma, saliva and dried blood spots.
    Donzelli M; Derungs A; Serratore MG; Noppen C; Nezic L; Krähenbühl S; Haschke M
    Clin Pharmacokinet; 2014 Mar; 53(3):271-282. PubMed ID: 24218006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenotypic Assessment of Drug Metabolic Pathways and P-Glycoprotein in Patients Treated With Antidepressants in an Ambulatory Setting.
    Lloret-Linares C; Bosilkovska M; Daali Y; Gex-Fabry M; Heron K; Bancila V; Michalopoulos G; Perroud N; Richard-Lepouriel H; Aubry JM; Desmeules J; Besson M
    J Clin Psychiatry; 2018; 79(2):. PubMed ID: 29570971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of fermented red ginseng on cytochrome P450 and P-glycoprotein activity in healthy subjects, as evaluated using the cocktail approach.
    Kim MG; Kim Y; Jeon JY; Kim DS
    Br J Clin Pharmacol; 2016 Dec; 82(6):1580-1590. PubMed ID: 27495955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lopinavir/ritonavir induces the hepatic activity of cytochrome P450 enzymes CYP2C9, CYP2C19, and CYP1A2 but inhibits the hepatic and intestinal activity of CYP3A as measured by a phenotyping drug cocktail in healthy volunteers.
    Yeh RF; Gaver VE; Patterson KB; Rezk NL; Baxter-Meheux F; Blake MJ; Eron JJ; Klein CE; Rublein JC; Kashuba AD
    J Acquir Immune Defic Syndr; 2006 May; 42(1):52-60. PubMed ID: 16639344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Geneva cocktail for cytochrome p450 and P-glycoprotein activity assessment using dried blood spots.
    Bosilkovska M; Samer CF; Déglon J; Rebsamen M; Staub C; Dayer P; Walder B; Desmeules JA; Daali Y
    Clin Pharmacol Ther; 2014 Sep; 96(3):349-59. PubMed ID: 24722393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiplex Phenotyping for Systems Medicine: A One-Point Optimized Practical Sampling Strategy for Simultaneous Estimation of CYP1A2, CYP2C9, CYP2C19, and CYP2D6 Activities Using a Cocktail Approach.
    de Andrés F; Terán S; Bovera M; Fariñas H; Terán E; LLerena A
    OMICS; 2016 Feb; 20(2):88-96. PubMed ID: 26600202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction between Fexofenadine and CYP Phenotyping Probe Drugs in Geneva Cocktail.
    Bosilkovska M; Magliocco G; Desmeules J; Samer C; Daali Y
    J Pers Med; 2019 Oct; 9(4):. PubMed ID: 31581637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of interaction potential of AZD2066 using in vitro metabolism tools, physiologically based pharmacokinetic modelling and in vivo cocktail data.
    Nordmark A; Andersson A; Baranczewski P; Wanag E; Ståhle L
    Eur J Clin Pharmacol; 2014 Feb; 70(2):167-78. PubMed ID: 24186263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Karolinska cocktail for phenotyping of five human cytochrome P450 enzymes.
    Christensen M; Andersson K; Dalén P; Mirghani RA; Muirhead GJ; Nordmark A; Tybring G; Wahlberg A; Yaşar U; Bertilsson L
    Clin Pharmacol Ther; 2003 Jun; 73(6):517-28. PubMed ID: 12811361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Red Ginseng on cytochrome P450 and P-glycoprotein activities in healthy volunteers.
    Kim DS; Kim Y; Jeon JY; Kim MG
    J Ginseng Res; 2016 Oct; 40(4):375-381. PubMed ID: 27746690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytochromes P450 and P-Glycoprotein Phenotypic Assessment to Optimize Psychotropic Pharmacotherapy: A Retrospective Analysis of Four Years of Practice in Psychiatry.
    Delage C; Darnaud L; Etain B; Vignes M; Ly TK; Frapsauce A; Veyrier M; Delavest M; Marlinge E; Hennion V; Meyrel M; Jacob A; Chouchana M; Smati J; Pataud G; Khoudour N; Fontan JE; Labat L; Bellivier F; Lloret-Linares C; Declèves X; Bloch V
    J Pers Med; 2022 Nov; 12(11):. PubMed ID: 36579580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Development and Validation of a Novel "Dual Cocktail" Probe for Cytochrome P450s and Transporter Functions to Evaluate Pharmacokinetic Drug-Drug and Herb-Drug Interactions.
    Kwon M; Jeon JH; Choi MK; Song IS
    Pharmaceutics; 2020 Sep; 12(10):. PubMed ID: 33007943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined phenotypic assessment of CYP1A2, CYP2C19, CYP2D6, CYP3A, N-acetyltransferase-2, and xanthine oxidase with the "Cooperstown cocktail".
    Streetman DS; Bleakley JF; Kim JS; Nafziger AN; Leeder JS; Gaedigk A; Gotschall R; Kearns GL; Bertino JS
    Clin Pharmacol Ther; 2000 Oct; 68(4):375-83. PubMed ID: 11061577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety of the Geneva Cocktail, a Cytochrome P450 and P-Glycoprotein Phenotyping Cocktail, in Healthy Volunteers from Three Different Geographic Origins.
    Rollason V; Mouterde M; Daali Y; Čížková M; Priehodová E; Kulichová I; Posová H; Petanová J; Mulugeta A; Makonnen E; Al-Habsi A; Davidson R; Al-Balushi KK; Al-Thihli K; Cerná M; Al-Yahyaee S; Černý V; Yimer G; Poloni ES; Desmeules J
    Drug Saf; 2020 Nov; 43(11):1181-1189. PubMed ID: 32851583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating the effect of type 2 diabetes mellitus on CYP450 enzymes and P-gp activities, before and after glycemic control: A protocol for a case-control pharmacokinetic study.
    Neyshaburinezhad N; Rouini M; Shirzad N; Esteghamati A; Nakhjavani M; Namazi S; Ardakani YH
    MethodsX; 2020; 7():100853. PubMed ID: 32337164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of deglucuronidation on the results of the Basel phenotyping cocktail.
    Bachmann F; Duthaler U; Krähenbühl S
    Br J Clin Pharmacol; 2021 Dec; 87(12):4608-4618. PubMed ID: 33890704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic assessment of a five-probe cocktail for CYPs 1A2, 2C9, 2C19, 2D6 and 3A.
    Turpault S; Brian W; Van Horn R; Santoni A; Poitiers F; Donazzolo Y; Boulenc X
    Br J Clin Pharmacol; 2009 Dec; 68(6):928-35. PubMed ID: 20002088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.